Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors

prnasiaAugust 04, 2021

Tag: NaviFUS , BBB , Brain tumors

PharmaSources Customer Service